AI filing briefs · archive

8-K filings in July 2026, explained

1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

4 of 1,916 briefs match

newest first · times in ET
KRUSKURA SUSHI USA, INC. Jul 7, 4:20 PM ET

Kura Sushi USA Q3 sales rise to $85.9 million; net income falls to $0.4 million

Mixed earnings Written later 2.02

Kura Sushi USA reported fiscal third-quarter 2026 results for the period ended May 31, 2026. Sales rose to $85.9 million from $74.0 million, but net income fell to $0.4 million, or $0.03 per diluted share, from $0.6 million, or $0.05 per share, a year earlier. The company reiterated its fiscal 2026 sales outlook of $330.5 million to $331.5 million and updated its guidance for the full year.

  • Total sales were $85.9 million, up from $74.0 million in the third quarter of 2025, while comparable restaurant sales decreased 0.4%.
  • Net income was $0.4 million, or $0.03 per diluted share, versus $0.6 million, or $0.05 per diluted share, a year earlier.
  • Restaurant-level operating profit was $16.4 million, or 19.1% of sales, compared with 18.2% a year earlier; Adjusted EBITDA was $6.6 million.
  • Seven new restaurants opened in the quarter, and the company had 91 restaurants at May 31, 2026.
Read the filing on SEC.gov ↗
XOMExxonMobil Holdings Corp Jul 7, 4:19 PM ET

ExxonMobil Holdings 2Q26 preview: liquids prices add $3.5 billion to $3.9 billion, impairments hit

Mixed earnings Written later 7.01

ExxonMobil Holdings furnished a preview of factors it expects to affect 2Q 2026 results compared with 1Q 2026, including market effects, planned activity and Middle East disruptions. The filing does not give a total 2Q 2026 earnings estimate, and the company says the list is not comprehensive. Shareholders get a mix of favorable and unfavorable items, with final 2Q results due July 31, 2026.

  • Change in liquids prices is estimated to add $3.5 billion to $3.9 billion to 2Q 2026 results versus 1Q 2026.
  • Upstream impairments are estimated at $0.8 billion to $1.0 billion, and other items including reserves at $1.2 billion to $1.4 billion.
  • Middle East events are estimated to reduce Upstream results by $0.6 billion to $0.8 billion through volume-related disruptions.
  • The company plans to release 2Q 2026 results at about 5:30 a.m. CT on Friday, July 31, 2026.
Read the filing on SEC.gov ↗
GNWGENWORTH FINANCIAL INC Jul 7, 4:10 PM ET

Genworth CEO McInerney takes health leave; CFO Jerome Upton named interim CEO

Mixed leadership Written later 5.02

Genworth Financial said CEO Thomas McInerney is taking a temporary leave of absence to focus on his health. CFO Jerome Upton, who has been with the company since 1998, was named Interim President and Chief Executive Officer effective July 7, 2026. The filing does not describe how long the leave will last or any change to the company's strategy.

  • Thomas J. McInerney, President and CEO, began a temporary leave of absence on July 7, 2026 to focus on his health
  • Jerome T. Upton, 62, CFO since March 2023, was appointed Interim President and CEO effective July 7, 2026
  • Board Chair Melina Higgins said the company plans to continue executing its existing strategy during the interim period
Read the filing on SEC.gov ↗
MGTXMeiraGTx Holdings plc Jul 7, 7:42 AM ET

MeiraGTx signs up to $375 million Oberland royalty financing, repays Perceptive notes

Mixed financing Written later 1.011.022.033.027.01

On June 30, 2026, MeiraGTx entered a royalty note purchase agreement with funds affiliated with Oberland Capital for up to $375 million, secured by company assets and tied to capped royalties on three gene therapy products. The company also agreed to sell 950,570 shares at $10.52 for about $10.0 million and fully redeemed its Perceptive credit notes on the same day. The royalty obligation and asset security add long-term commitments for shareholders, though the funding is non-dilutive apart from the small equity sale.

  • Initial purchase of $100 million on June 30, 2026, with a second purchase of $25 million scheduled for July 17, 2026
  • Revenue Payments equal to 1.95% of global net sales of AAV-AIPL1, AAV-hAQP1 and bota-vec, subject to a cap and payable after marketing approval
  • Sale of 950,570 shares at $10.52 per share for about $10.0 million, with closing on July 17, 2026
  • Full redemption of Perceptive notes on June 30, 2026, with no early termination penalties
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.